Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Australia's Therapeutic Goods Administration (TGA) issues warning on resterilisation:

This article was originally published in Clinica

Executive Summary

Australia's Therapeutic Goods Administration has issued a Safety Alert warning on the potential damage to medical devices caused by inappropriate resterilisation methods. The warning relates to the dangers of autoclaving Zirconia ceramic components in orthopaedic implants. It states that autoclaving causes microscopic surface roughening, which in turn accelerates wear and may lead to early implant failure and possible osteolysis. It also draws attention to the risk of resterilising any unused medical device which may accidentally be contaminated before use because the appropriate sterilisation method may not always be obvious.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT089782

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel